Publications and communications of Christophe Bonnet

Douven, U., Janssens, A., Crochet, G., Bailly, S., Bonnet, C., Jacquy, C., Offner, F., Snauwaert, S., Van den Neste, E., Vercruyssen, M., Dierickx, D., Vandenberghe, P., & Vergote, V. (June 2023). BHS GUIDELINES ON THE MANAGEMENT OF RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: PART 2. Belgian Journal of Hematology, 14, 170-177.

Douven, U., Janssens, A., Crochet, G., Bailly, S., Bonnet, C., Jacquy, C., Offner, F., Snauwaert, S., Van Den Neste, E., Vercruyssen, M., Dierickx, D., Vandenberghe, P., & Vergote, V. (May 2023). BHS guidelines on the management of relapsed and refractory diffuse large B-cell lymphoma: Part 1. Belgian Journal of Hematology, 14, 114-121.

Aubrais, R., Bouabdallah, K., Chartier, L., Herbaux, C., Banos, A., Brice, P., Sibon, D., Schiano, J. M., Cluzeau, T., Laribi, K., LE Calloch, R., Bellal, M., Delapierre, B., Daguindau, N., Amorim, S., Agbetiafa, K., Chauchet, A., Besson, C., Durot, E., ... Parrens, M.-C. (2023). Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA. Blood Advances. doi:10.1182/bloodadvances.2022008524

Fornecker, L.-M., Lazarovici, J., Aurer, I., Casasnovas, R.-O., Gac, A.-C., Bonnet, C., Bouabdallah, K., Feugier, P., Specht, L., Molina, L., Touati, M., Borel, C., Stamatoullas, A., Nicolas-Virelizier, E., Pascal, L., Lugtenburg, P., Di Renzo, N., Vander Borght, T., Traverse-Glehen, A., ... LYSA-FIL-EORTC Intergroup. (2023). Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial. Journal of Clinical Oncology, 41, 327 - 335. doi:10.1200/JCO.21.01281

Veloza, L., Cavalieri, D., Missiaglia, E., Ledoux-Pilon, A., Bisig, B., Pereira, B., Bonnet, C., Poullot, E., Quintanilla-Martinez, L., Dubois, R., Llamas-Gutierrez, F., Bossard, C., De Wind, R., Drieux, F., Fontaine, J., Parrens, M., Sandrini, J., Fataccioli, V., Delfau-Larue, M.-H., ... De Leval, L. (2023). Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. Haematologica, 108, 181 - 195. doi:10.3324/haematol.2022.281226

Nicolae, A., Bouilly, J., Lara, D., Fataccioli, V., Lemonnier, F., Drieux, F., Parrens, M., Robe, C., Poullot, E., Bisig, B., Bossard, C., Letourneau, A., Missiaglia, E., Bonnet, C., Szablewski, V., Traverse-Glehen, A., Delfau-Larue, M.-H., de Leval, L., & Gaulard, P. (August 2022). Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. Modern Pathology, 35, 1126 - 1136. doi:10.1038/s41379-022-01022-w

BONNET, C., Dupuis, J., Tilly, H., Lamy, T., Fruchart, C., le Gouill, S., Thieblemont, C., Morschhauser, F., Casasnovas, O., Bouabdallah, K., Ghesquieres, H., Van Den Neste, E., André, M., Cartron, G., & Salles, G. (30 March 2022). Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group. Cancers, 14, 1761. doi:10.3390/cancers14071761

Casasnovas, R.-O., Bouabdallah, R., Brice, P., Lazarovici, J., Ghesquieres, H., Stamatoullas, A., Dupuis, J., Gac, A.-C., Gastinne, T., Joly, B., Bouabdallah, K., Nicolas-Virelizier, E., Feugier, P., Morschhauser, F., Sibon, D., Bonnet, C., Berriolo-Riedinger, A., Edeline, V., Parrens, M., ... Rossi, C. (2022). Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study. Journal of Clinical Oncology, 40, 1091 - 1101. doi:10.1200/JCO.21.01777

Jullien, M., Tessoulin, B., Ghesquières, H., Oberic, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Villemagne, B., Gressin, R., Bouabdallah, K., Haioun, C., Damaj, G., Fornecker, L.-M., Schiano De Colella, J.-M., Feugier, P., Hermine, O., Cartron, G., ... Le Gouill, S. (07 September 2021). Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years. Cancers, 13, 4503. doi:10.3390/cancers13184503

Buedts, L., Wlodarska, I., Finalet-Ferreiro, J., Gheysens, O., Dehaspe, L., Tousseyn, T., Fornecker, L.-M., Lazarovici, J., Casasnovas, R.-O., Gac, A.-C., BONNET, C., Bouabdallah, K., Copie-Bergman, C., Fabiani, B., Dierickx, D., Marcelis, L., Vermeesch, J., André, M., & Vandenberghe, P. (2021). The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA. Blood Advances, 5, 1991-2002. doi:10.1182/bloodadvances.2020003039

Camus, V., Rossi, C., Sesques, P., Lequesne, J., Tonnelet, D., Haioun, C., Durot, E., Willaume, A., Gauthier, M., Moles-Moreau, M.-P., Antier, C., Lazarovici, J., Monjanel, H., Bernard, S., Tardy, M., Besson, C., Lebras, L., Choquet, S., Le Du, K., ... Tilly, H. (2021). Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study. Blood Advances, 5, 3862-3872. doi:10.1182/bloodadvances.2021004778

Le Gouill, S., Ghesquieres, H., Obéric, L., Morschhauser, F., Tilly, H., Ribrag, V., Lamy, T., Thieblemont, C., Maisonneuve, H. G., Gressin, R., Bouabdallah, K., Haioun, C., Damaj, G., Fornecker, L. M., Bouabdallah, R., Feugier, P., Sibon, D., Cartron, G., BONNET, C., ... Casasnovas, O. (2021). Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA. Blood, 137 (17), 2307-2320. doi:10.1182/blood.2020008750

MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481.

Oberic L., Peyrade F., Puyade M., BONNET, C., Dartigues-Cuillères P., Fabiani B., Ruminy P., Maisonneuve H., Abraham J., Thieblemont C., Feugier P., Salles G., Bijou F., Pica GM., Damaj G., Haioun C., Casasnovas RO., Farhat H., Le Calloch R., ... Jardin F. (2021). Subcutaneous Rituximab-MiniCHOP compared with subcutaneous Rituximab-MiniCHOP plus Lenalidomide in diffuse large B-Cell lymphoma for patients age 80 years or older. Journal of Clinical Oncology, 39, 1203-1213. doi:10.1200/JCO.20.02666

RADERMECKER, A., BONNET, C., LUTTERI, L., CHAPELLE, A.-C., PETIGNOT, S., LIEVENS, I., & CAERS, J. (2021). Un cas illustratif de syndrome de POEMS. Revue Médicale de Liège, 76, 156-159.

Houot, R., Cartron, G., Bijou, F., de Guibert, S., Salles, G. A., Fruchart, C., Bouabdallah, K., Maerevoet, M., Feugier, P., Le Gouill, S., Tilly, H., Casasnovas, R.-O., Moluçon-Chabrot, C., Van Den Neste, E., Zachee, P., André, M., Bonnet, C., Haioun, C., Van Hoof, A., ... Morschhauser, F. (2019). Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study. Leukemia, 33, 776-780. doi:10.1038/s41375-018-0282-y

Morschhauser F., Le Gouill S., Feugier P., Bailly S., Nicolas-Virelizier E., Bijou F., Salles GA., Tilly H., Fruchart C., Van Eygen K., Snauwaert S., BONNET, C., Haioun C., Thieblemont C., Bouabdallah R., Wu KL., Canioni D., Meignin V., Cartron G., & Houot R. (2019). Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. The Lancet Haematology, 6, 429-e437. doi:10.1016/S2352-3026(19)30089-4

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

Cabannes-Hamy, A., Peyrade, F., Jardin, F., Emile, J., Delwail, V., Mounier, N., Haioun, C., Perrot, A., Fitoussi, O., Lara, D., Delarue, R., André, M., Offner, F., Gherquières, H., Pascal, L., Soussain, C., Lazarovici, J., Schiano, J., Gaulard, P., ... BONNET, C. (Other coll.). (2018). Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies. Cancer Medicine. doi:10.1002/cam4.1139

Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., WILLEMS, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., BOUABDALLAH, R., SALLES, G., & BACHY, E. (2018). Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers. Annals of Oncology, 29, 715-723. doi:10.1093/annonc/mdx787

FOSSARD, G., BROUSSAIS, F., COELHO, I., BAILLY, S., NICOLAS-VIRELIZIER, E., TOUSSAINT, E., LANCESSEUR, C., LE COTTEREAU, A., EL-GALALY, T., BECKER, S., PETERSON, L., Bonnet, C., PRIOR, J., TILLY, H., HUTCHINGS, M., CASASNOVAS, O., & MEIGNAN, M. (2018). Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients. European Journal of Nuclear Medicine, 59. doi:10.2967/jnumed.117.193946

Vergote, V., Janssens, A., André, M., Bonnet, C., Van Hende, V., Van Den Neste, E., Van Eygen, K., Maerevoet, M., Pranger, D., Schroyens, W., Debussche, S., Maertens, V., Beel, K., Lemmens, J., Caron, C., Delrieu, V., Van Den Broeck, I., Vanstraelen, G., Jacquy, C., ... Van Hoof, A. (22 February 2017). Results from the Belgian mantle cell lymphoma registry. Acta Clinica Belgica, 38, 1-7. doi:10.1080/17843286.2017.1293328

Bron, D., Aurer, I., Bonnet, C., Caballero, D., Falandry, C., Kimby, E., Soubeyran, P., Zucca, E., Bosly, A., Coiffier, B., & André, M. (2017). Unmet needs in the scientific approach to older patients with lymphoma. Haematologica, 102 (6), 972-975. doi:10.3324/haematol.2017.167619

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

Vallois, D., Dobay, M. P. D., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B., Roberti, A., Grewal, J., Bruneau, J., Fabiani, B., Martin, A., Bonnet, C., Michielin, O., Jais, J.-P., Figeac, M., Bernard, O. A., ... de Leval, L. (15 September 2016). Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas. Blood, 128, 1490-1502. doi:10.1182/blood-2016-02-698977

Springael, C., Delrieu, V., Wu, K. L., Schroyens, W., Bonnet, C., Bron, D., & Janssens, A. (June 2016). BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias. Belgian Journal of Hematology, 7, 103-111.

Cottereau, A. S., Becker, S., Broussais, F., Casasnovas, O., Kanoun, S., Roques, M., Charrier, N., Bertrand, S., Delarue, R., Bonnet, C., Hustinx, R., Gaulard, P., de Leval, L., Vera, P., Itti, E., Mounier, N., Haioun, C., Tilly, H., & Meignan, M. (April 2016). Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†. Annals of Oncology, 27, 719-724. doi:10.1093/annonc/mdw011

Pilorge, S., Harel, S., Ribrag, V., Larousserie, F., Willems, L., Franchi, P., Legoff, M., Biau, D., Anract, P., Roux, C., Blanc-Autran, E., Delarue, R., Gisselbrecht, C., Ketterer, N., Recher, C., Bonnet, C., Peyrade, F., Haioun, C., Tilly, H., ... Tamburini, J. (2016). Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies. Leukemia and Lymphoma, 57, 2820-2826. doi:10.1080/10428194.2016.1177180

BONNET, C., & BOSLY, A. (October 2015). Highlights of the 13th International Conference on Malignant Lymphoma. Belgian Journal of Hematology, 6 (4), 173-178.

VAN HENDE, V., BRON, D., VAN DEN NESTE, E., BONNET, C., ANDRE, M., VAN HOOF, A., DIERICKX, D., VERHOEF, G., TOUSSEYN, T., JANSSENS, A., DE WILDE, V., WU, K. L., & HEIMANN, P. (October 2015). Waldenström's macroglobulinaemia: Belgian Hematology Society guidelines. Belgian Journal of Hematology, 6 (4), 142-151.

BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69.

Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556.

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.

SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78.

JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948.

MOURIN, E., VAN HOOF, A., BOSLY, A., Bonnet, C., DE WILDE, V., DOYEN, C., HERMANS, C., JANSSENS, A., MICHAUX, L., SCHROYENS, W., SONET, A., VAN DEN NESTE, E., VERHOEF, G., ZACHEE, P., & ANDRE, M. (September 2014). Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society. Belgian Journal of Hematology, 5, 89.

BRON, D., VAN DEN NESTE, E., KENTOS, A., OFFNER, F., SCHROYENS, W., Bonnet, C., VAN HOOF, A., VERHOEF, G., & JANSSENS, A. (March 2014). BHS guidelines for the treatment of marginal zone lymphomas. Belgian Journal of Hematology, 5, 12-17.

André, M., DE PRIJCK, B., Kentos, A., Van Hoof, A., Bonnet, C., Sonet, A., Maerevoet, M., Van Den Neste, E., Bosly, A., & Mounier, N. (2014). ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III - IV low risk Hodgkin Lymphoma (IPS 0-2): final results of LYSA H34 trial. Belgian Journal of Hematology, 12.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333

SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18.

SOMJA, J., Bisig, B., de Leval, L., Bonnet, C., HERENS, C., & Siebert, R. (2014). Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly. Virchows Archiv. doi:10.1007/s00428-014-1560-3

Bonnet, C., MENTEN, C., LAMBERT, F., Gothot, A., Baron, F., CAERS, J., HERENS, C., & Beguin, Y. (25 January 2013). Simultaneous diagnosis of CLL and CML in a single patient with evidence for two different cell clones [Poster presentation]. BHS, General Annual Meeting.

BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552

Bisig, B., de Reyniès, A., Bonnet, C., Sujobert, P., Rickman, D. S., Marafioti, T., Delsol, G., Lamant, L., Gaulard, P., & de Leval, L. (2013). CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica, 98/n°8, 1250-1258. doi:10.3324/haematol.2012.081935

Bossard, C., Dobay, M. P., Lamant, L., Missiglia, E., Parrens, M., Martin, A., Tournillac, O., Haioun, C., Bonnet, C., Berger, F., Bouchind'homme, B., Delarue, R., Rousset, T., Thiebault, S., Picquenot, J., Fabiani, B., Delorenzi, M., Gaulard, P., & de Leval, L. (2013). Correlation between RNA and protein levels in a large european series from the LYSA. Hematological Oncology, 31 Suppl.1, 146-147.

JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16.

Ketterer, N., Coiffier, B. B., Thieblemont, C., Fermé, C., Brière, J. F., Casasnovas, O., Bologna, S., Christian, B., Connerotte, T., Récher, C., Bordessoule, D., Fruchart, C., Delarue, R., Bonnet, C., Morschhauser, F. A., Anglaret, B., Soussain, C., Fabiani, B., Tilly, H., & Haioun, C. (2013). Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Annals of Oncology, 24/n°4, 1032-1037. doi:10.1093/annonc/mds600

Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013

Van Obbergh, F., Van Hoof, A., Verhoef, G., Dierickx, D., De Wilde, V., Offner, F., Bron, D., Sonet, A., André, M., Janssens, A., Bonnet, C., DE PRIJCK, B., Zachée, P., Kentos, A., Schroyens, W., & Van Den Neste, E. (2013). Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS). Belgian Journal of Hematology, 4 (3), 90-101.

Verhoef, G., Schroyens, W., Bron, D., Bonnet, C., De Wilde, V., Van Hoof, A., Janssens, A., Dierickx, D., André, M., & Van Den Neste, E. (2013). Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL. Belgian Journal of Hematology, 4 (2), 51-57.

Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90.

de Leval, L., BONNET, C., Copie-Bergman, C., SEIDEL, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study. Annals of Oncology. doi:10.1093/annonc/mds150

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T. J., Fabiani, B., Petrella, T., Bosq, J., Gisselbrecht, C., Siebert, R., Tilly, H., Haioun, C., Fillet, G., & Gaulard, P. (2012). Diffuse large B-cell lymphoma of Waldeyer's ring has distinc clinicopathologic features: a GELA study. Annals of Oncology, 23(12), 3143-3151.

Debussche, S., Van Hoof, A., Sonet, A., Bonnet, C., Janssens, A., Verhoef, G., Dierickx, D., De Wilde, V., Bron, D., Schroyens, W., Van Den Neste, E., & Offner, F. (2012). Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma 2012. Belgian Journal of Hematology, 3 (2), 41-50.

Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649.

CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643.

Récher, C., Coiffier, B., Haioun, C., Molina, T. J., Fermé, C., Casasnovas, O., Thièblement, C., Bosly, A., Laurent, G., Morschhauser, F., Ghesquières, H., Jardin, F., Bologna, S., Fruchart, C., Corront, B., Gabarre, J., Bonnet, C., Janvier, M., Canioni, D., ... Tilly, H. (2011). Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. The Lancet, 378(9806), 1858-1867. doi:10.1016/S0140-6736(11)61040-4

Bosly, A., Delarue, R., Bonnet, C., Van Hoof, A., Van Den Neste, E., Maerevoel, M., Zachée, P., Bron, D., Mathieux, V., Fournier, M., Molina, T., Haioun, C., & Tilly, H. (2010). R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-ell lymphoma: results of the interim analysis of the LNH03- GELA study [Poster presentation]. 25th General Meeting of the Belgian Hematological Society.

Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176.

Beguin, Y., Maertens, J., DE PRIJCK, B., Schots, R., Frère, P., Bonnet, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., LEJEUNE, M., SERVAIS, S., THeunissen, K., Fillet, G., & Baron, F. (2009). A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation [Poster presentation]. 24th General Meeting of the Belgian Hematological Society, Oostende, Belgium.

Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.

Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248

de Leval, L., Bonnet, C., Brière, J., Molina, T., Petrella, T., Bosq, J., Falini, B., Gisselbrecht, C., Reyes, F., Fillet, G., & Gaulard, P. (2008). Diffuse large B-cell lymphoma (DLBCL) of the waldeyer'ring (WR) frequently have a GC-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annals of Oncology, 13(suppl 4), 366.

Bonnet, C. (2007). Contribution à l'étude des lymphomes: Aspects pronostiques et thérapeutiques [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/160761

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T. J., Thieblemont, C., Ferme, C., Quesnel, B., Brassiene, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (01 March 2007). CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de I'Adulte. Journal of Clinical Oncology, 25 (7), 787-792. doi:10.1200/JCO.2006.07.0722

Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x

Bonnet, C., & Fillet, G. (2007). How can we determine the role of radiotherapy in the treatment of localized aggressive non Hodgkin's lymphoma? Journal of Clinical Oncology, 25/n°19, 2857-2858.

de Leval, L., Bonnet, C., Copie-Bergman, C., Seidel, L., Baia, M., Brière, J., Molina, T., Fabiani, B., Falini, B., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse large B-cell lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Annual Meeting Abstracts, 110, 1561.

de Leval, L., Bonnet, C., Copie-Bergmann, C., Seidel, L., Brière, J., Molina, T., Fabiani, B., Brunangelo, F., Gisselbrecht, C., Thilly, H., Albert, A., Fillet, G., & Gaulard, P. (2007). Diffuse Large B-cell Lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA). Blood.

De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90.

Trimeche, M., Bonnet, C., Korbi, S., Boniver, J., & de Leval, L. (2007). Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study. Leukemia and Lymphoma, 48 (7), 1323-1331. doi:10.1080/10428190701411177

Bonnet, C., Beguin, Y., FASSOTTE, M.-F., & Fillet, G. (2006). Limited usefulness of CA 125 measurement in the management of hodgkin's and non-hodgkin's lymphomas [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (January 2006). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressie lymphoma: final results of the LNH 93-4 GELA Study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Bonnet, C., Fillet, G., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Ferme, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2006). No role for chemoradiotherapy compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study [Poster presentation]. 21st General Meeting of the Belgian Hematological Society.

Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255

Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society.

Fillet, G., Bonnet, C., Mounier, N., Ganem, G., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes, F. (2005). No role for chemoradiotherapy when compared with chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: final results of the LNH93-4 GELA study. Blood, 106 (15).

Fillet, G., Bonnet, C., Mounier, N., Ganem, N., Molina, T., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Gisselbrecht, C., Tilly, H., & Reyes. (2005). No advantage of chemoradiotherapy over chemotherapy alone in elderly patients with localized low risk aggressive lymphoma: results of the LNH93-4 GELA study. Annals of Oncology, 16 (suppl 5).

WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075).

Gillain, S., Gennigens, C., Sautois, B., Polus, M., Bonnet, C., Fillet, G., & Jerusalem, G. (2004). Traitement du cancer du sein chez la personne âgée. Revue Médicale Suisse, 62, 1618-21.

Bonnet, C., Fillet, G., Bosly, A., Van Hoof, A., Offner, F., Van Den Neste, E., DE PRIJCK, B., Deflandre, A., Gisselbrecht, C., & Reyes, F. (2003). Radiotherapy is unnecessary in elderly patients with localized aggressive non hodgkin's lymphoma: results of the LNH 93-4 study [Paper presentation]. 18th General Meeting of the Belgian Hematological Society, Brussels, Belgium.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Annals of Oncology, 13 (suppl 2), 27.

Bonnet, C., Fillet, G., Mounier, N., Thieblemont, C., Fermé, C., Quesnel, B., Martin, C., Blanc, M., Conroy, T., Penny, A. M., Petrella, T., & Reyes, F. (2002). Radiotherapy is unnecessary in elderly patients with localized agressive non Hodgkin's lymphoma: results of the LNH 93-4 study. Blood, 100 (11), 92.

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.

Malgrange, B., LEFEBVRE, P., van de Water, T. R., Bonnet, C., Monville, F., Rigo, J.-M., Staecker, H., & Moonen, G. (1998). In vitro ototoxicity of aminoglycosides and platin derivatives. A semi-automatic assay for sensory hair cell damage in explanted rat organ of corti. Toxicology in Vitro, 12 (6), 705-714. doi:10.1016/S0887-2333(98)00048-4